Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
05 February 2024
The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:
| PDMR | Date of transaction | No. of shares vested | No. of shares granted | No. of shares sold or withheld |
| Christopher J. Ball | 31 January 2024 | 493,000 | 99,525 | 0 |
| Christopher J. Ball | 1 February 2024 | 0 | 0 | 114,423 |
| Christopher J. Ball | 2 February 2024 | 0 | 0 | 118,144 |
| Jason E. Doughty | 31 January 2024 | 344,647 | 0 | 0 |
| Jason E. Doughty | 1 February 2024 | 0 | 0 | 66,616 |
| Jason E. Doughty | 2 February 2024 | 0 | 0 | 69,025 |
| Ronald W. Glass | 31 January 2024 | 85,000 | 50,000 | 0 |
| Ronald W. Glass | 1 February 2024 | 0 | 0 | 17,525 |
| Ronald W. Glass | 2 February 2024 | 0 | 0 | 18,115 |
| Andrew G. Inglis | 31 January 2024 | 837,500 | 270,600 | 0 |
| Andrew G. Inglis | 1 February 2024 | 0 | 0 | 166,524 |
| Andrew G. Inglis | 2 February 2024 | 0 | 0 | 171,941 |
| Neal D. Shah | 31 January 2024 | 423,000 | 148,500 | 0 |
| Neal D. Shah | 1 February 2024 | 0 | 0 | 84,672 |
| Neal D. Shah | 2 February 2024 | 0 | 0 | 87,655 |
The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
Josh R. Marion
Assistant Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Christopher J. Ball |
| b) | Position / status | SVP and Chief Commercial Officer |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | (1) 493,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 99,525 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 6.06 | |
| Volume | 592,525 | |
| Total | 3,590,701.50 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 6.06 | |
| Volume | 592,525 | |
| Total | 3,590,701.50 | |
| f) | Date of the transactions | 31 January 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 114,423 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 6.0287 | |
| Volume | 114,423 | |
| Total | 689,821.94 | |
| e) | Aggregated information | |
| Price | 6.0287 | |
| Volume | 114,423 | |
| Total | 689,821.94 | |
| f) | Date of the transactions | 1 February 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 118,144 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 5.8388 | |
| Volume | 118,144 | |
| Total | 689,819.19 | |
| e) | Aggregated information | |
| Price | 5.8388 | |
| Volume | 118,144 | |
| Total | 689,819.19 | |
| f) | Date of the transactions | 2 February 2024 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Jason E. Doughty |
| b) | Position / status | SVP and General Counsel |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 344,647 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 6.06 | |
| Volume | 344,647 | |
| Total | 2,088,560.82 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 6.06 | |
| Volume | 344,647 | |
| Total | 2,088,560.82 | |
| f) | Date of the transactions | 31 January 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 66,616 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 6.0287 | |
| Volume | 66,616 | |
| Total | 401,607.88 | |
| e) | Aggregated information | |
| Price | 6.0287 | |
| Volume | 66,616 | |
| Total | 401,607.88 | |
| f) | Date of the transactions | 1 February 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 69,025 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 5.8388 | |
| Volume | 69,025 | |
| Total | 403,023.17 | |
| e) | Aggregated information | |
| Price | 5.8388 | |
| Volume | 69,025 | |
| Total | 403,023.17 | |
| f) | Date of the transactions | 2 February 2024 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Ronald W. Glass |
| b) | Position / status | Vice President and Chief Accounting Officer |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | (1) 85,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 50,000 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 6.06 | |
| Volume | 135,000 | |
| Total | 818,100 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 6.06 | |
| Volume | 135,000 | |
| Total | 818,100 | |
| f) | Date of the transactions | 31 January 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 17,525 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 6.0287 | |
| Volume | 17,525 | |
| Total | 105,652.97 | |
| e) | Aggregated information | |
| Price | 6.0287 | |
| Volume | 17,525 | |
| Total | 105,652.97 | |
| f) | Date of the transactions | 1 February 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 18,115 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 5.8388 | |
| Volume | 18,115 | |
| Total | 105,769.86 | |
| e) | Aggregated information | |
| Price | 5.8388 | |
| Volume | 18,115 | |
| Total | 105,769.86 | |
| f) | Date of the transactions | 2 February 2024 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Andrew G. Inglis |
| b) | Position / status | Chairman and Chief Executive Officer |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | (1) 837,500 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 270,600 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 6.06 | |
| Volume | 1,108,100 | |
| Total | 6,715,086 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 6.06 | |
| Volume | 1,108,100 | |
| Total | 6,715,086 | |
| f) | Date of the transactions | 31 January 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 166,524 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 6.0287 | |
| Volume | 166,524 | |
| Total | 1,003,923.24 | |
| e) | Aggregated information | |
| Price | 6.0287 | |
| Volume | 166,524 | |
| Total | 1,003,923.24 | |
| f) | Date of the transactions | 1 February 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 171,941 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 5.8388 | |
| Volume | 171,941 | |
| Total | 1,003,929.11 | |
| e) | Aggregated information | |
| Price | 5.8388 | |
| Volume | 171,941 | |
| Total | 1,003,929.11 | |
| f) | Date of the transactions | 2 February 2024 |
| g) | Place of the transaction | NYSE |
| 1. | Details of PDMR / person closely associated with them ("PCA") | |
| a) | Name | Neal D. Shah |
| b) | Position / status | Senior Vice President and Chief Financial Officer |
| c) | Initial notification / amendment | Initial notification |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | (1) 423,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 148,500 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder. |
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 6.06 | |
| Volume | 571,500 | |
| Total | 3,463,290 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| e) | Aggregated information | |
| Price | 6.06 | |
| Volume | 571,500 | |
| Total | 3,463,290 | |
| f) | Date of the transactions | 31 January 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 84,672 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 6.0287 | |
| Volume | 84,672 | |
| Total | 510,462.09 | |
| e) | Aggregated information | |
| Price | 6.0287 | |
| Volume | 84,672 | |
| Total | 510,462.09 | |
| f) | Date of the transactions | 1 February 2024 |
| g) | Place of the transaction | NYSE |
| 2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument | Common Stock, par value $0.01 per share |
| b) | Nature of the transactions | 87,655 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
|
| Shares Granted or Vested | ||
| c) | Currency | USD |
| Price | 0 | |
| Volume | 0 | |
| Total | 0 | |
| Shares sold or withheld | ||
| d) | Currency | USD |
| Price | 5.8388 | |
| Volume | 87,655 | |
| Total | 511,800.01 | |
| e) | Aggregated information | |
| Price | 5.8388 | |
| Volume | 87,655 | |
| Total | 511,800.01 | |
| f) | Date of the transactions | 2 February 2024 |
| g) | Place of the transaction | NYSE |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.